Developed by the Moscow-based Gamaleya Research Institute of Epidemiology and Microbiology, Sputnik V was the first SARS-Cov-2 vaccine to be registered anywhere in the world. The vaccine has been pre-ordered by over a dozen nations, with dozens more expressing interest.